• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Prof. Jeanette Leusen, PhDEd van Rijswijk

Novel first-in-class antibodies block inflammation pathway in autoimmune diseases

antibodies, autoimmune diseases, 4 December 2025/in E-News /by panglobal

Researchers at UMC Utrecht have developed two novel antibodies that specifically target the high-affinity IgG receptor FcγRI, offering a potential therapeutic approach for autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus, and immune thrombocytopenia. The antibodies, designated C01 and C04, effectively block immune complex binding without triggering receptor activation, addressing a key limitation of previous […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/12/Center-for-Translational-Immunology-Leusen-Group.jpg 467 700 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-04 08:00:422025-12-03 13:57:43Novel first-in-class antibodies block inflammation pathway in autoimmune diseases
Schematic illustration of the noninvasive closed-loop spinal interface.© TMIMS

Non-invasive spinal stimulation restores stepping control in paraplegic patients

paraplegia, spinal stimulation, 3 December 2025/in E-News, MedTech, Neurology /by panglobal

Researchers in Japan have developed a breakthrough non-invasive closed-loop spinal stimulation system that enables individuals with paraplegia to regain control of leg stepping movements. The hand-controlled magnetic stimulation technique bypasses spinal cord lesions and strengthens preserved neural circuits, offering a surgical-free alternative for gait rehabilitation after spinal cord injury.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/12/spinal.jpg 844 1474 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-12-03 13:49:412025-12-03 13:49:41Non-invasive spinal stimulation restores stepping control in paraplegic patients

UK government commits £74 million to life sciences innovation

London Life Sciences Week, UK life sciences, 28 November 2025/in E-News /by panglobal

The UK government has announced over £74 million in combined government and industry funding to support eight research and development projects focused on transforming pharmaceutical manufacturing and addressing critical healthcare challenges.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/07/SNMMI_mars_shot_fund.png 495 938 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-11-28 09:48:382025-11-28 09:48:38UK government commits £74 million to life sciences innovation

CAR T cells reduce atherosclerosis by 70% in mouse study

atherosclerosis, CAR-T therapy, 28 November 2025/in Cardiovascular Disease, E-News, Research /by panglobal

Scientists at the University of Pennsylvania’s Perelman School of Medicine have demonstrated that chimeric antigen receptor (CAR) T cell therapy could offer a novel approach to treating atherosclerosis.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/06/shutterstock_1535060051-scaled.jpg 621 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-11-28 09:27:522025-11-28 09:27:52CAR T cells reduce atherosclerosis by 70% in mouse study
rare diseases, sickle cell disease

UK’s MHRA signals major regulatory overhaul for rare disease therapies

rare diseases, 24 November 2025/in E-News /by panglobal

The Medicines and Healthcare products Regulatory Agency has committed to a fundamental restructuring of the UK’s rare disease therapy regulatory framework, with detailed guidelines scheduled for publication in 2026. The announcement represents the most significant shift in rare disease treatment pathways undertaken by the regulator and forms part of the Government’s broader life sciences strategy.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/11/rare_disease.jpeg 586 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-11-24 11:33:192025-11-24 11:33:19UK’s MHRA signals major regulatory overhaul for rare disease therapies
UNIVERSITY OF BARCELONA

Unlocking brown fat: cellular autophagy mechanism holds key to age-related metabolic decline

adipose tissue, metabolism, 21 November 2025/in E-News, Research /by panglobal

Researchers have identified chaperone-mediated autophagy as a critical regulator of brown adipose tissue thermogenic activity, revealing that age-related decline in this selective protein degradation pathway drives metabolic dysfunction. The findings, published in Science Advances, demonstrate that pharmacological activation of this mechanism can restore brown fat function in aged mice, opening therapeutic avenues for obesity and […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/11/brown_fat-team.jpg 842 1166 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-11-21 07:00:142025-11-19 13:06:44Unlocking brown fat: cellular autophagy mechanism holds key to age-related metabolic decline
NHS gig doctor

Thousands of UK doctors trapped in NHS gig economy contracts, investigation reveals

, 20 November 2025/in E-News /by panglobal

A BMJ investigation reveals almost nine in 10 NHS acute trusts use local employment contracts that trap thousands of doctors – predominantly international medical graduates and ethnic minorities – in roles lacking training opportunities, career progression, and nationally agreed safeguards. Some doctors remain in these precarious positions for over a decade.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/11/gig_doctor.png 600 600 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-11-20 01:40:402025-11-19 12:53:52Thousands of UK doctors trapped in NHS gig economy contracts, investigation reveals
Siemens Healthineers announces strategic restructuring with new Precision Therapy segment

Siemens Healthineers unveils restructuring plan with new precision therapy segment

precision therapy, Siemens Healthineers, 19 November 2025/in E-News /by panglobal

Siemens Healthineers has announced a comprehensive strategic restructuring at its Capital Markets Day in London, introducing a new reporting framework centred on three distinct segments and targeting annual revenue growth of 5-7% through fiscal year 2030.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/11/Siemens-global-health.png 718 783 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-11-19 12:38:142025-11-19 12:38:14Siemens Healthineers unveils restructuring plan with new precision therapy segment
tirzepatide food cravings

Research shows first direct evidence of weight-loss drug influence on brain signals linked to food cravings

• Tirzepatide, food cravings, GLP-1 therapy, Nucleus accumbens, 18 November 2025/in E-News, obesity, pharmacology /by panglobal

A pioneering study tracking brain activity in patients taking the weight-loss drug tirzepatide has uncovered distinctive neural patterns associated with food preoccupation, offering the first direct evidence of how incretin-based therapies modulate reward circuitry in humans. The research reveals a specific low-frequency brain signal that precedes intense food cravings and demonstrates how pharmacological intervention may […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/11/food_craving.png 800 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-11-18 04:00:452025-11-14 08:59:19Research shows first direct evidence of weight-loss drug influence on brain signals linked to food cravings

Clinicians urged to revitalise bedside strategies as technology reshapes patient care

bedside medicine, clinical examination, diagnostic technology, medical education, physician burnout, 17 November 2025/in E-News, Patient Experience /by panglobal

A new report in the New England Journal of Medicine outlines six practical strategies to strengthen fundamental clinical skills and restore the doctor-patient relationship in an increasingly technology-driven healthcare environment.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2025/11/doctor_patient.png 800 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2025-11-17 08:00:412025-11-14 08:44:43Clinicians urged to revitalise bedside strategies as technology reshapes patient care
Page 2 of 240‹1234›»

Latest issue of International Hospital

April 2024

7 January 2026

Gulf Aorta Summit 2026 Returns to Dubai with a Global Lineup of Aortic Experts

17 December 2025

GE HealthCare receives CE mark for 128cm total body PET/CT

16 December 2025

HOPS 2026 Returns to Dubai — Setting a New Benchmark for Oncology Pharmacy in the Middle East

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription